Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a spine-focused medical device company whose news flow centers on spine surgery innovation, financial performance, and strategic collaborations. Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., ATEC regularly issues updates on procedural technologies, imaging platforms, and neuro-monitoring systems that support its goal of revolutionizing spine surgery.
Investors and clinicians following ATEC news can expect frequent announcements of quarterly and annual financial results, including commentary on surgical revenue, EOS revenue, adjusted EBITDA, and free cash flow. The company often pairs its earnings releases with updated full-year outlooks, highlighting trends in surgical volume growth, new surgeon adoption, and the performance of its procedural ecosystems such as PTP™ and LTP™.
ATEC’s news stream also features product and platform launches, such as the commercial introduction of the PTP™ Corpectomy system, which expands its Prone TransPsoas approach to complex thoracolumbar pathologies. These announcements provide detail on systems like the Sigma™ LIF Corpectomy Access System, Ascend™ NanoTec™ Vertebral Body Replacement System, and SafeOp™ Neural InformatiX™ System, illustrating how the company integrates access, implants, and neuro-monitoring into a unified procedural offering.
Strategic and corporate developments are another recurring theme. Recent news includes a definitive partnership with Theradaptive, Inc. granting ATEC exclusive U.S. commercial rights to OsteoAdapt®, an osteoinductive bone graft for spinal fusion built on AMP2™ protein technology. The company also issues releases about participation in major healthcare and medtech conferences, board-related updates, and inducement equity awards for new employees. This news page aggregates these items so readers can track how ATEC’s spine-only strategy, innovation pipeline, and financial trajectory evolve over time.
Alphatec Holdings, Inc. (ATEC) reported Q2 2021 financial results, revealing total revenues of $62.2 million and a GAAP gross margin of 66.0%. Operating expenses reached $76.8 million, resulting in a GAAP operating loss of $(35.8 million). Notably, 84% of revenue stemmed from new products, up from 61% in Q2 2020. The company forecasts $238 million in total revenue for the fiscal year, a 64% increase year-over-year. The recent acquisition of EOS imaging aims to enhance ATEC's clinical capabilities.
Alphatec Holdings, Inc. (ATEC), a leader in innovative spine surgery solutions, announced their participation in several investor conferences. Key events include:
- Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 2:30 pm ET
- UBS Genomics 2.0 and MedTech Innovations Summit on August 12, 2021, at 3:00 pm ET
- 6th Annual Needham Virtual MedTech Conference on August 16, 2021
- Piper Sandler MedTech and Diagnostics California Bus Tour on August 25, 2021
Webcasts of these presentations will be available on ATEC's Investor Relations page for 90 days.
Alphatec Holdings, Inc. (ATEC) announced the appointment of Beth Altman as an independent director and Chair of the Audit Committee, effective August 12, 2021. Altman, previously Managing Partner at KPMG LLP San Diego, brings extensive expertise in life sciences and technology. The company also shared the resignation of Donald A. Williams from the Board, effective August 11, 2021. Pat Miles, Chairman and CEO, emphasized Altman's significance in ATEC's transformation into a leading spine company.
Alphatec Holdings, Inc. (ATEC) reported strong preliminary revenue growth for Q2 2021. U.S. organic revenue is projected between $55.4 million and $56.0 million, representing a growth of 92.1% to 94.2% year-over-year. Total revenue, excluding EOS imaging, is expected to range from $55.8 million to $56.4 million, showing growth of 88.2% to 90.2%. The company anticipates full-year 2021 organic revenue growth to exceed 50%. Alphatec's cash position stands at $74.0 million as of June 30, 2021, bolstered by $40.0 million in available borrowings.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced the appointment of Marie Meynadier, Ph.D., as an independent director on its board. Dr. Meynadier, with over 25 years of experience in high tech and medical devices, previously founded EOS imaging and served as its CEO until 2018. Her expertise is expected to enhance ATEC's integration of EOS imaging technologies and support the company's strategy for international expansion. The announcement indicates a strategic move to leverage her imaging expertise as ATEC strives to establish new standards in spine surgery.
Alphatec Holdings (Nasdaq: ATEC) announced the acquisition of EOS imaging, enhancing its capabilities in spine surgery. This combination aims to improve patient outcomes through better surgical information and planning. The ATEC Informed by EOS™ initiative promises to provide actionable data that aligns with preoperative plans, significantly impacting alignment objectives and long-term clinical outcomes. EOS technology introduces advanced imaging and diagnostic capabilities, while ATEC's solutions will integrate with EOS’s platform to deliver customized surgical interventions.
ATEC announced it successfully secured approximately 89.1% of EOS imaging's common shares and voting rights as of May 13, 2021. ATEC's tender offer resulted in the acquisition of 15,815,971 shares and 2,312,074 convertible bonds, with the total holdings reaching 23,756,061 shares. ATEC also holds 57.2% of EOS's outstanding OCEANEs. The AMF will reopen the offer on May 17, 2021, allowing additional shareholders to participate at prices of €2.45 per share and €7.01 per OCEANE.
Alphatec Holdings, Inc. (ATEC) announced that Chairman and CEO Pat Miles will present at the Canaccord Genuity Virtual Musculoskeletal Conference on May 20, 2021, at 1:30 pm EDT. This event aims to showcase ATEC's innovative spine surgery solutions. Additionally, ATEC management will hold meetings with registered attendees. A webcast of the presentation will be available online for 90 days on the Company's investor relations website, ensuring broader access to their updates.
Alphatec Holdings (ATEC) reported a robust 50% revenue growth for Q1 2021, totaling $44.1 million, with U.S. revenue at $43.7 million and a gross margin of 73.1%. The company is experiencing market expansion, with new products contributing to 77% of U.S. revenue. ATEC anticipates full-year revenues of approximately $190 million, driven by continued innovation and product launches, despite an expected 33% growth in U.S. revenue due to the winding down of an international supply agreement.
Alphatec Holdings, Inc. (ATEC) announced it will release its first quarter 2021 financial results on May 6, 2021, after market close. The live webcast will occur at 1:30 p.m. PT / 4:30 p.m. ET, providing investors with insights into the company’s performance. Investors are encouraged to register early to participate in the event. A replay will be available for twelve months, allowing stakeholders to review the results and discussions at their convenience.